US Broker Ratings

Galapagos NV (GLPG): Unpacking the 1,093% Revenue Growth and What It Means for Investors

Investors with an eye on the biotechnology sector might find Galapagos NV (NASDAQ: GLPG) a compelling company to consider, especially given its striking revenue growth of..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Unpacking a 35.24% Upside Potential

Edgewise Therapeutics, Inc. (EWTX), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its promising 35.24% potential upside. The company’s focus..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Robust Growth Potential with 23% Upside

Investors eyeing opportunities in the healthcare sector may want to take a closer look at Kiniksa Pharmaceuticals International (NASDAQ: KNSA). With a market capitalization of $3.49..

Ardent Health, Inc. (ARDT) Stock Analysis: A 37.83% Potential Upside in Focus for Investors

Ardent Health, Inc. (NYSE: ARDT) stands out in the healthcare sector as a robust player in the medical care facilities industry. With a market capitalization of..

Organon & Co. (OGN) Stock Analysis: Key Insights on Its 25.17% Potential Upside

For investors with a keen interest in the healthcare sector, Organon & Co. (NYSE: OGN) offers a compelling case study. With a market capitalization of $1.87..

Crinetics Pharmaceuticals (CRNX) Stock Analysis: Unpacking a 105% Potential Upside for Growth Investors

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is capturing the attention of growth-oriented investors with its compelling development pipeline and an eye-catching potential upside of 105.26%. The company,..

ICU Medical, Inc. (ICUI) Investor Outlook: A 24% Upside Potential Amid Healthcare Innovation

ICU Medical, Inc. (NASDAQ: ICUI) presents a compelling opportunity for investors seeking exposure in the healthcare sector, particularly within the medical instruments and supplies industry. With..

ImmunityBio, Inc. (IBRX) Stock Analysis: A Biotech Powerhouse with 29% Upside Potential

ImmunityBio, Inc. (NASDAQ: IBRX) stands as a formidable player in the biotechnology sector, capturing investor interest with its innovative approach to immunotherapy. With a market cap..

Select Medical Holdings Corp (SEM) Stock Analysis: Discover the 14.27% Potential Upside in Healthcare

Select Medical Holdings Corporation (NYSE: SEM) stands as a formidable entity within the healthcare sector, particularly in the medical care facilities industry. With a market capitalization..

Addus HomeCare Corporation (ADUS) Stock Analysis: Potential 33% Upside for Savvy Investors

Addus HomeCare Corporation (NASDAQ: ADUS) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of..

Enovis Corporation (ENOV): Investor Outlook on a Promising 75.8% Potential Upside

Investors seeking opportunities in the healthcare sector may find Enovis Corporation (ENOV) an intriguing choice, especially with a potential upside of 75.8% as indicated by the..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Promising Biotech with 35.82% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical leader in rare and orphan diseases, is making waves in the biotechnology sector with its innovative therapies and robust..

Bausch Health Companies Inc. (BHC) Stock Analysis: Unveiling a Potential 29.65% Upside

Bausch Health Companies Inc. (NYSE: BHC), a diversified specialty pharmaceutical and medical device company headquartered in Laval, Canada, is a name that has long been associated..

Metsera, Inc. (MTSR) Stock Analysis: Biotechnology Innovator Faces Potential Downside Despite Strong Buy Ratings

Metsera, Inc. (MTSR), a clinical-stage biotechnology company based in New York, is making waves in the healthcare sector with its promising pipeline of hormone analog peptides..

CRISPR Therapeutics AG (CRSP) Investor Outlook: Biotechnology Innovator Poised for a 39.51% Upside

CRISPR Therapeutics AG (NASDAQ: CRSP) stands as a compelling player in the biotechnology sector, with its innovative focus on gene editing technologies. This Swiss company has..

Arrowhead Pharmaceuticals, Inc. (ARWR)

⚠️ No article content returned.

..

Tarsus Pharmaceuticals (TARS) Stock Analysis: Strong Buy Ratings and 21.88% Upside Potential

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) stands at the forefront of the biopharmaceutical industry with a primary focus on eye care therapeutics. The company’s strategic developments and..

HUTCHMED (China) Limited (HCM) Stock Analysis: Potential Upside of 51.89% Amid Unique Growth Opportunities

HUTCHMED (China) Limited (HCM), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, presents an intriguing investment opportunity with..

Warby Parker Inc. (WRBY) Investor Outlook: Eyeing a 9.04% Upside with Strong Buy Ratings

Warby Parker Inc. (NYSE: WRBY) is shaping up as an intriguing opportunity for investors in the healthcare sector, specifically within the Medical Instruments & Supplies industry...

Denali Therapeutics Inc. (DNLI) Investor Outlook: Analyzing the 56.80% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company at the forefront of developing treatments for neurodegenerative and lysosomal storage diseases, is capturing investor attention with a..

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds